Belgian INAMI has published updates for the List of reimbursable implants and medical devices in August

31

Aug 2017

New material codes for spinal distraction system and platinum surgical sealant for contact with lung tissue were added to the List of reimbursable devices of the Belgian National Institute for Health and Disability Insurance (INAMI-RIZIV) in August. Codes for application of intramedullary nails were changed, and conditions of reimbursement for valvulotomy and percutaneous closure of the left atrial appendage were amended.

New procedure codes and related conditions of reimbursement have been implemented for the following devices:

Spinal distraction system

  • Devices will be reimbursed via generic tariff under condition of registration in the  Nominative lists 36601 and 36602
  • The following procedure codes have been implemented:
    • 182210 – 182221 “Extendable magnetic rod for bracing to the spine by screws, hooks and/or connectors” with the tariff of €12,000;
    • 182232 – 182243 “Replacement extendable magnetic rod for bracing to the spine by screws, hooks and/or connectors” with the tariff of €12,000;
    • 182254 –  182265 “Extendable magnetic rod for bracing to the spine by screws, hooks and/or connectors, in case of early replacement” with the tariff of €12,000;
    • 182276 – 182280 “Additional magnetic rod for bracing to the spine by screws, hooks and/or connectors” with the tariff of €6,000;
    • 182291 – 182302 “Replacement extendable magnetic rod for bracing to the spine by screws, hooks and/or connectors” with the tariff of €6,000;
    • 182313 – 182324 “Replacement extendable magnetic rod for bracing to the spine by screws, hooks and/or connectors, in case of early replacement” with the tariff of €6,000.
  • There are specific conditions of reimbursement of these technologies, provided in paragraphs L-§30 of the List of reimbursable implants and medical devices.

Surgical adhesive for internal use specifically intended for use in contact with lung tissue

  • Devices will be reimbursed via generic tariff under condition of registration in the Nominative list 32904;
  • The following material codes have been implemented:
    • 182195 – 182206 “Surgical adhesive for internal use specifically intended for use in contact with lung tissue (by intervention)” with the tariff of €518,53 (€285,19 or 55% is reimbursed by patient);
  • There are specific conditions of reimbursement of these technologies, provided in paragraph K-§01 of the List of reimbursable implants and medical devices.

INAMI has modified procedure code 167974 - 167985 “Nail assembled centromedullary telescopic (which stretches as the bone grows)” with the tariff of €3,498. Devices will be reimbursed via generic tariff and under the condition of registration in the Nominative list 36701.

Conditions of reimbursement have been modified for the following procedures:

  • Valvulotomy in paragraph G-§08 of the List of reimbursable implants and medical devices;
  • Percutaneous closure of the left atrial appendage in paragraph F-§23 of the List of reimbursable implants and medical devices.

See the updated version of the List in French and Dutch here.

Subscribe to our newsletter delivered every second week not to miss important reimbursement information.

The latest related news

22

Mar 2022

On February 17, 2022, the Federal Joint Committee (G-BA) has decided to include the method of matrix-associated autologous chondrocyte implantation (M-ACI) on the knee joint in the case of symptomatic cartilage damage in the lists of reimbursed procedures in the hospital and ambulatory settings.

Read more

18

Mar 2022

On February 22, 2022, a repository of innovative acts outside the nomenclature of biology and anatomopathology (RIHN) and a Supplementary list of IVD tests were published. Minor changes were introduced in the 2022 RIHN list.

Read more

15

Mar 2022

The Belgian Health Care Knowledge Center (KCE) initiated a study aimed at defining a clear and transparent procedure for the evaluation of digital health technologies in Belgium.

Read more

14

Mar 2022

In February 2021, the Clinical Coding and Schedule Development (CCSD) working group, which develops and maintains procedural and diagnostics nomenclature for private payers in England, published Bulletins 0182 and 0079 with changes to be implemented no later than April 10, 2022. Three new procedure codes concerned robotic surgery in orthopaedic area, spinal procedures, and ophthalmology, and five new diagnostic codes were introduced.

Read more

08

Mar 2022

At the end of February 2022, the Dental and Pharmaceutical Benefits Agency (TLV) has launched a theme survey on products for monitoring and diagnostics of sepsis to identify products that may be relevant for health economic assessments at TLV. The suggestions for the products of interest, ongoing clinical studies, or innovation projects could be received until 23 March 2022.

Read more